RT Journal Article
T1 Infective endocarditis on transcatheter aortic prosthesis: Are there differences with endocarditis on surgically implanted aortic bioprosthesis?
A1 Fernandez-Aviles, Consuelo
A1 Castillo, Juan C
A1 Heredia, Gloria
A1 Resua, Adriana
A1 Gonzalez, Rafael
A1 Pan, Manuel
A1 Anguita, Manuel
K1 Endocarditis
K1 Endocarditis, bacterial
K1 Heart valve prosthesis
K1 Heart valve prosthesis implantation
AB Transcatheter aortic valve implantation (TAVI) has been a major advance in the treatment of aortic stenosis in elderly patients or those at very highsurgical risk, and its indication has been extended to cases of high or even intermediate risk. For this reason, its use has increased notably in thepast years [1]. One of the problems associated with TAVI is bioprosthesis infection [2]. The development of infective endocarditis (IE) on TAVI(IETAVI) is a serious complication, with the added problem that in many cases open-heart surgery is necessary to manage it.
PB Wydawnictwo Via Medica
YR 2021
FD 2021-10-28
LK http://hdl.handle.net/10668/21659
UL http://hdl.handle.net/10668/21659
LA en
NO Fernández-Avilés C, Castillo JC, Heredia G, Resúa A, González R, Pan M, et al.  Infective endocarditis on transcatheter aortic prosthesis: Are there differences with endocarditis on surgically implanted aortic bioprosthesis? Cardiol J. 2022;29(3):511-513
DS RISalud
RD Apr 9, 2025